Introduction
Chronically elevated left ventricular (LV) afterload is one of the leading causes of heart failure (HF) and is associated with high morbidity, mortality, and societal costs. 1, 2 Thus, new therapeutic options are sorely needed. Increased understanding of the mechanisms underlying pathological cardiac remodelling is central to the development of novel HF therapies, 3 and reproducible in vivo experimental systems that allow for thorough exploration of mechanisms are required. 4, 5 Surgically induced HF models are widely used in cardiac research. For decades suture-based thoracic aortic constriction (TAC) has been the preferred method for increasing LV afterload in rodents. The procedure, first described by Rockman et al. in 1991, 6 has provided invaluable insight into the underlying molecular mechanisms governing cardiac remodelling and failure and, in combination with genetically modified animals, has been instrumental for mapping the role of central molecular players. Reproducibility is in high demand and expected in cardiac research. 4 Suture-based TAC has produced variability in LV remodelling and dysfunction leading to subgroups of failing and compensated cardiac phenotypes. [7] [8] [9] [10] For instance, suture-based TAC using a 27G needle in C57BL/6J mice results in increased LV mass varying from 42% to 376% 8-9 weeks after surgery. 11, 12 Moreover, mortality rates vary substantially, i.e. <25%, [13] [14] [15] [16] 25-50%, [17] [18] [19] and 50-75%. 7, 20, 21 Such variations obviously complicate and confound the interpretation of mechanistic data. Dissection of the specific mechanisms underlying development of clinically relevant cardiac phenotypes resulting from increased LV afterload such as HF with reduced ejection fraction (HFrEF) and compensated hypertrophy, rely on precise animal models mimicking those disease states. Generation of improved models would, therefore, represent major steps forward in the field. Thus, our aim was to develop a method for highly reproducible, precise aortic constriction in mice to generate more predictable cardiac remodelling and disease progression. We subjected mice to constriction of the ascending aorta using o-rings with fixed inner diameters (IDs), i.e. o-ring aortic banding (ORAB).
Methods

Ethics
Mouse experiments were performed in agreement with the Guide for the Care and Use of Laboratory Animals (NIH publication No. 85-23, revised 2011, US) and approved by the Norwegian National Animal Research Committee (approval #8041 and #8617). The reporting of experimental procedures and results was performed in accordance with the ARRIVE guidelines. 22 
Experimental animals
Male, 9-week-old (23.5 ± 0.1 g) C57BL/6J mice (Janvier Labs, Le GenestSaint-Isle, France) and 8-10 weeks old FVB/N (24.6 ± 0.4 g) male NFATluciferase reporter (NFAT-luc) mice were randomized for sham, sham with inserted nitrile rubber piece (sham rub) or ORAB with IDs of 0.71 mm (ORAB 0.71), 0.66 mm (ORAB 0.66), or 0.61 mm (ORAB 0.61). The o-ring sizes chosen for the study were determined based on echocardiographic assessment of the C57BL/6J aortic diameter and supplied by Apple Rubber (Lancaster, NY, USA). NFAT-luc mice were kindly provided by Dr Jeffery D. Molkentin (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA) and carry nine copies of the NFAT-binding site from the interleukin-4 promoter, upstream of the luciferase gene. 23 The C57BL/6J mice were followed for 2 (n = 43), 4
(n = 51), or 20 weeks (n = 49). A cohort of C57BL/6J sham rub and ORAB 0.66 animals (n = 20) underwent pressure-volume measurements 12 weeks post-surgery. Surgery was performed by one mouse surgeon. For evaluation of inter-operator variability, a cohort of ORAB 0.61 C57BL/6J mice (n = 6) was operated by a second mouse surgeon and harvested 4 weeks post-surgery. Animals received pre-and postoperative analgesia (6 h post-surgery) by subcutaneous injection of 0.02 mL (0.3 mg/mL) buprenorphine. Additional analgesics were administered subject to animal status. Mice were housed in cages of six animals per cage with ad libitum supply of food and water under 12/12 h light/ dark cycles. At the end of experiments, hearts and lungs were weighed before the hearts were cut at the transverse midventricular plane. The basal bi-ventricular part was used for histology, while the apical part of the LV was snap-frozen in liquid nitrogen and stored for RNA or protein analyses. Whole LVs from NFAT-luc mice (n = 41) were assessed for luciferase activity 2 weeks post-surgery. Tibias were measured for organ weight normalization.
ORAB for induction of pressure overload in mice
O-rings were prepared for operations by opening the ring with a lateral cut ( Figure 1A and Supplementary material online, Figure S1A ) before a non-absorbable 6-0 suture (VS-802, Covidien/Medtronic, Dublin, Ireland) was thread through the resulting ends at a parallel angle to the opening cut (see Supplementary material online, Figure S1B ). Suture (1.5-2 cm) was left on each side of the ring ends. Mice were intubated and ventilated, breathing 98% oxygen and 2% isoflurane. While fixed in the supine position on top of a heating pad, a 1-1.5 cm longitudinal incision in the skin on the left side of the thorax was made using blunt scissors. After retracting the major and minor pectoral muscles, the 3rd intercostal muscle was pierced using a blunt strong curved iris forceps and the resulting passage was expanded by a pair of ball tip scissors. The ascending aorta was accessed by retracting the costae and the thymus. Fat surrounding the aorta was trimmed away using ring tip forceps to reduce variation in the degree of constriction. The suture ends from the same side of the open ring were passed under the aorta using modified spinal cord hook (see Supplementary material online, Figure S1C ). Sutures, on both sides of the aorta ( Figure 1A ), were grasped and pulled to open the o-ring and place it around the aorta ( Figure 1B) . The lower and upper sutures were tied separately with two sets of overhand knots, thereby forcing the o-ring to close ( Figure 1C) . Excess suture was cut ( Figure 1D ), and the lungs were inflated to avoid pneumothorax. The residing incision was covered by the pectoral muscles, and the skin was closed with continuous sutures. Animals were kept on ventilation until commencing of voluntary breathing. A video of the procedure can be found in the Supplementary material online.
Sham-operated animals were subjected to the same operation, but without insertion of an o-ring. Sham rub animals received a small piece of nitrile rubber on top of the aorta to control for possible effects of nitrile rubber. The average operation time for ORAB was 12 ± 1 min, sham-surgery was conducted in 8 ± 1 min.
Echocardiography and magnetic resonance imaging
Echocardiographic assessment of LV dimensions in diastole and systole (i.e. wall thicknesses and ID) and left atrium diameter (LAD) were performed by an experienced researcher blinded to group in lightly anaesthetized mice breathing 1.75% isoflurane through a mask, using the VEVO 2100 (VisualSonics, Toronto, Canada). 24 Doppler-imaging of preand post-stenotic maximal flow velocities were captured 24 h postsurgery and trans-stenotic pressure gradients were calculated using the Simplified Bernoulli equation (DP = 4(v 2 post -v 2 pre )). v 2 pre was not included when lower than 1.5 m/s in accordance with previous recommendations. 25 The 9.4 T magnetic resonance imaging (MRI) system (Agilent, Palo Alto, CA, USA) with a 35 mm quadrature-driven birdcage RF coil (Rapid Biomedical, Rimpar, Germany) was used by an experienced researcher blinded to group for assessment of LV mass, LV enddiastolic volume (LVEDV), LV ejection fraction (LVEF), LV lumen length, and cardiac output (CO). Anaesthesia given by mask during MRIcaptures was between 1% and 2% isoflurane, in order to maintain stable respiration and heart rate. Cine-MRI was acquired in the true short-axis and the four-chamber long-axis orientation in a cardiac and respiratorygated manner. 
Pressure-volume assessment of cardiac diastolic function
LV catheterization was performed using an open-chest approach, as previously described. 26 In short, mice were intubated and ventilated, and the thorax opened through the diaphragm using a cauterizer. A channel was created to the LV lumen by an apical stab with a 25G needle and a 1F Millar pressure-volume catheter (PVR-1045; Millar Instruments, Houston, TX, USA) was inserted. End-diastolic pressure-volume relationship (EDPVR) was calculated from pressure-volume cycles recorded in triplicates using LabVIEW (National Instruments, Austin, TX, USA) during inferior vena cava occlusion. Volume was adjusted to enddiastolic and end-systolic volumes acquired from prior MRI measurements.
Histochemistry
The bi-ventricular base of the heart was rinsed in PBS and fixed in 10% formalin for a minimum of 24 h. Fixed hearts were paraffin-embedded and sectioned at the mid-ventricular plane at 4 mm. Collagen abundance was assessed by Masson's trichrome staining (25088; Polysciences, Inc., Warrington, PA, USA) according to the manufacturer's protocol. Stained sections were scanned and fibrosis area (%) quantified by a researcher blinded to group using the ZEN 2 blue edition software (Zeiss, Jena, Germany).
RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from snap frozen LV tissue using the TissueLyser II (Qiagen Nordic, Oslo, Norway) and RNeasy mini (74106, Qiagen), according to the manufacturer's protocol. cDNA synthesis was performed using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Transcript levels were assessed using TaqMan assays (Applied Biosystems, Foster City, CA, USA; listed in Supplementary material online) on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). Results were analysed using the Sequence Detection System 2.3 software (Applied Biosystems). mRNA levels were normalized to Rpl32 transcript values, which remained stable at all time points (see Supplementary material online, Figure S2 ).
Protein isolation and immunoblotting
Snap-frozen LV tissue was homogenized using the TissueLyser II (Qiagen), in 1Â PBS-based lysis buffer essentially as described. 24 SDS-PAGE separation was performed before transfer onto PVDF membranes. After incubation with primary and HRP-conjugated secondary antibodies (listed in Supplementary material online), membranes were developed using ECL Prime (Amersham/GE HealthCare, Buckinghamshire, UK) on the Las-4000 (Fujifilm, Tokyo, Japan). Densitometry and image processing were performed using ImageJ (NIH) and Photoshop CS5.1.
NFAT-luciferase activity
Frozen, whole LVs from NFAT-luc mice were homogenized twice at 30 Hz for 100 s using the TissueLyser II (Qiagen), as described in the Luciferase Assay System protocol (Promega, WI, USA) and as described previously. 27 Samples were kept on ice, vortexed and centrifuged at 12 000 g for 30 s. Luminescence was quantified on the Hidex Sense Microplate Reader (Finland).
Statistics
All presented data are mean ± SEM. 
Results
ORAB results in negligible post-operative mortality
The 2-week post-operative ORAB survival rate was 98.7%, i.e. ORAB resulted in only two deaths from 152 operations. Necropsies revealed thoracic bleeding in both animals (ORAB 0.71 died at Day 1, ORAB 0.71 
ORAB results in reproducible and graded myocardial hypertrophy
The three ORAB groups showed increased LV posterior wall (LVPW) diameter compared with sham rub animals 2-20 weeks post-surgery ( Figure 2A and Supplementary material online, Table S1 ). ORAB 0.66 and 0.61 showed increased LVPW already at 1 week post-surgery. Similarly, increased interventricular septum diameter (IVS) was evident in all three ORAB groups 8-20 weeks after operation, with increased IVS in ORAB 0.61 mice also at 1-2 weeks post-surgery ( Figure 2A and Supplementary material online, Table S1 ). A graded increase in LVPW and IVS was observed among the ORAB groups, in accordance with the ID of the o-ring. LV mass calculated from MRI was increased 1 week post-ORAB in the 0.61 and 0.66 groups, whereas all three ORAB groups showed increased LV mass from 8 to 20 weeks post-surgery ( Figure 2B and Supplementary material online, Table S2 ). Importantly, with reduced o-ring ID, the degree of hypertrophic remodelling was increased. Finally, heart weight measured at harvest confirmed the findings from echocardiography and MRI, showing increased hearts weight in the ORAB 0.66 and 0.61 groups at 2 weeks and in all groups at 4 and 20 weeks post-ORAB ( Figure 2C) . The highest increase was observed in the ORAB 0.61, thus, ORAB resulted in a reproducible and graded hypertrophic response.
ORAB results in reproducible and graded cardiac dilatation and dysfunction
LVEF decreased early in the ORAB 0.61, 1 week post-ORAB ( Figure 3A and Supplementary material online, Table S2 ) and continued to decline, reaching 26% at 20 weeks post-surgery. The decompensated phenotype in ORAB 0.61 was associated with reduced fractional shortening (FS) (see Supplementary material, Table S1 ) and CO (see Supplementary material online, Table S2 ) at 8 weeks post-surgery. A decrease in LVEF was seen in the ORAB 0.71 and 0.66 groups at 8-20 weeks post-ORAB compared with sham rub mice, but without a continued decline within this time frame ( Figure 3A and Supplementary material online, Table S2 ). Neither showed decreased FS (see Supplementary material online, Table S1 ) or Table S2 ), confirming the stabilized phenotype. Thus, ORAB resulted in a reproducible and graded cardiac contractile dysfunction.
CO (see Supplementary material online,
In accordance with the gradually declining LV function of the ORAB 0.61, we observed an increase in LVEDV 14-20 weeks postsurgery ( Figure 3B and Supplementary material online, Table S2 ), but no alterations before these time points. In the ORAB 0.61, this might be explained by the early concentric narrowing of the diastolic LV inner diameter (LVID) ( Figure 3C and Supplementary material online, Table S1 ). LV lumen length was increased in all ORAB groups, but most profound in ORAB 0.61 ( Figure 3D and Supplementary material online, Table S2 ). When combined with the relative increase in LVID seen in the ORAB 0.61 from 4 to 20 weeks, this explained the overall dilated phenotype of this model, reflected by the increased LVEDV.
In agreement with the severe phenotype of the ORAB 0.61, LAD was increased from 1 to 20 weeks post-ORAB ( Figure 3E and Supplementary material online, Table S1 ). Accordingly, ORAB 0.61 mice presented with increased lung weight at 2 and 4 weeks, and with severely congested lungs at 20 weeks post-surgery ( Figure 3F To assess whether ORAB resulted in diastolic dysfunction in mice with a stabilized reduction in LVEF, LV pressure-volume dynamics were assayed in ORAB 0.66 mice 12 weeks post-surgery. ORAB 0.66 mice had an increased EDPVR slope compared to sham rub animals (see Supplementary material online, Table S3 ), indicating increased myocardial stiffness and diastolic dysfunction.
Signature molecules of cardiac remodelling and failure show a graded expression profile to ORAB
Expression profiles of signature genes of cardiac remodelling were assayed in LVs harvested at 2, 4, and 20 weeks post-ORAB ( Figure 4A -C, respectively). All ORAB groups had elevated mRNA levels of natriuretic peptides Nppa and Nppb compared with the sham rub 2 weeks postsurgery ( Figure 4A ). In accordance with the exacerbated degree of remodelling of ORAB 0.61 mice, this group had substantially higher levels of Nppa and Nppb compared with the other ORAB groups. The enhanced concentric hypertrophic growth in the ORAB 0.61 was supported by increased Acta1 mRNA levels at 2 weeks. We did not detect major changes in Myh6 mRNA levels after ORAB, but observed a graded increase in Myh7 expression, consistent with the switch of myosin heavy chain isoforms during pathological cardiac hypertrophy. ORAB 0.66 and 28 supporting that the observed remodeling in these groups was of a pathological nature despite lack of congestive HF.
mice expressed increased levels of foetal genes associated with adverse remodelling
ORAB induces a graded fibrotic response
LV fibrosis was assessed at 2, 4, and 20 weeks post-ORAB. mRNA levels of the fibrillar collagens Col1a2 and Col3a1 were markedly increased in the ORAB 0.61 at 2-4 weeks, compared with the other groups ( Figure  5A and B). Transcript levels of the collagen crosslinking enzyme lysyl oxidase (Lox) was increased in all ORAB groups compared with sham rub animals at 2 weeks, with the highest levels in the ORAB 0.61 ( Figure 5A ), suggesting a stiffer collagen matrix. mRNA levels of transforming growth factor beta 1 (Tgfb1) were increased in the ORAB 0.61 at 2-4 weeks post-surgery compared with sham rub animals ( Figure 5A and B) . Moreover, the transcript levels of the pro-fibrotic mediator connective tissue growth factor (Ctgf) was higher in the ORAB 0.61 at all timepoints, but also increased in the ORAB 0.66 ( Figure 5A-C) . Histological examination of heart cross sections stained for collagen protein were consistent with the mRNA data, showing increased LV fibrosis in the ORAB 0.61 at all time-points ( Figure 6A and B) . Some fibrosis was detected in the ORAB 0.66 at 4 weeks postsurgery.
The more prominent fibrotic phenotype of the ORAB 0.61 was also evident from increased mRNA and protein levels of the myofibroblast signature gene alpha-smooth muscle actin (Acta2 gene encoding the a-SMA protein) at 2 weeks post-ORAB ( Figure 6C) . 
ORAB activates central cardiac remodelling signalling pathways and remodelling-associated inflammation
Activation of central cardiac remodelling signalling pathways was examined 2 weeks post-ORAB (Figure 7) . Levels of phosphorylated ERK2 protein were increased in ORAB 0.61 mice animals compared with all the other groups ( Figure 7A ), while we did not detect changes in ERK1 phosphorylation. We did, however, observe an increase in total ERK1 and 2 protein levels in the ORAB-operated mice, which were graded to the o-ring ID. AKT activation was evident in all ORAB groups. p38 was only activated in the ORAB 0. 61 . NFAT activation was measured by NFAT-luciferase activity in FVB/N NFAT-luc reporter mice ( Figure 7B) . Consistent with the exacerbated phenotype of the ORAB 0.61 seen by increased LV weight, NFAT activation was increased in this group when 
compared with the sham rub controls. In agreement, mRNA levels of the NFAT target gene Rcan1. 4 were increased in the ORAB 0.61 in wildtype C57BL/6J mice ( Figure 7C) . Thus, ORAB activates specific central cardiac remodelling signalling pathways subject to the ORAB ID chosen.
As the regulation of pro-inflammatory cytokines has been shown to occur in the early stages of cardiac remodelling following increased afterload, 29 we measured the LV mRNA levels of tumour necrosis factor alpha (Tnf), interleukin 1beta (Il1b), interleukin 6 (Il6), and interleukin 18 (Il18) 2 weeks post-ORAB ( Figure 7D ). mRNA levels of Tnf, Il1b, and Il18 were up-regulated in ORAB 0.61 compared with sham rub, whereas Il18 transcript abundance was also increased in ORAB 0.66. Il6 mRNA levels were higher in ORAB 0.61 compared with all other groups, but also elevated in ORAB 0.66. Hence, the transcriptional regulation of pro-inflammatory genes suggested that inflammation was enhanced in accordance with the degree of constriction produced by the different orings.
ORAB is performed with high intra-and inter-surgeon reproducibility
Evaluation of the intra-operator reproducibility was performed by calculating the coefficient of variation (CV) of heart weights within the sham rub and ORAB groups harvested at 2, 4, and 20 weeks post-surgery. The average CV values of the measured heart weights within the ORAB groups were 10.8%, 12.2%, and 17.0% at 2, 4, and 20 weeks, respectively, compared with 4.6%, 8.8%, and 8.1% in the sham rub. Although all animals were included, CV values for heart weight remained low. Thus, ORAB was performed with high intra-surgeon reproducibility. To examine the inter-surgeon variation of the ORAB method, ORAB 0.61 was performed by a second surgeon with minimal ORAB training. Both ORAB 0.61 groups had similar increases in LV wall thicknesses, LAD, heart weight, and lung weight compared with sham rub animals 4 weeks post-surgery (see Supplementary material online, Table S4 ). Consistently, LV mRNA levels of natriuretic peptides (Nppa, Nppb), Acta1, Myh7, and collagens (Col1a2 and Col3a1) were up-regulated to a similar extent compared with sham rub animals.
Post-surgical exclusion is minimal with ORAB
Degree of constriction in suture-based TAC of the ascending aorta is traditionally validated by echocardiographic measurement of the poststenotic maximal flow velocity (V max ) 24 h post-surgery (see Supplementary material online, Figure S3A) . 27 All ORAB-operated groups had an average post-stenotic V max of 4 m/s or higher (see Supplementary material online, Figure S3B ). ORAB 0.66 had a higher post-stenotic V max compared with ORAB 0.71 (4.5 m/s vs. 4 .1 m/s), but ORAB 0.61 did not differ from the other groups despite the tighter stenosis. The same result was seen when calculating the trans-stenotic pressure gradient (see Supplementary material online, Figure S3C ). This could be explained by the reduced LV function seen in the ORAB 0.61, as maximal pre-stenotic V max and FS were lower in the ORAB 0.61 animals (see Supplementary material online, Figure S3D and E). Given that gradients are a squared function of flow, even a modest decrease in flow may lead to a significant reduction in gradient. 30 The ID of the o-ring was a better determinant of disease progression compared with the post-stenotic V max , and we could include all operated animals while maintaining limited variation and reproducible cardiac phenotypes. Similarly, we did not exclude any mice due to adverse effects of the oring material, as cardiac function and structural parameters (see Supplementary material online, Table S5 ), organ weights and molecular markers (see Supplementary material online, Table S6 ) were similar in the sham rub and sham groups.
Discussion
We have developed a novel method for constriction of the ascending aorta in mice using fixed diameter o-rings. This technique results in highly reproducible pressure overload-induced remodelling with negligible post-operative mortality. The fixed ID of the o-rings allow for standardized degrees of aortic constriction. By using gradually narrower o-rings, we induced a corresponding increasing degree of hypertrophic remodelling, diastolic and systolic dysfunction, and congestive HF.
Aortic constriction as a model of chronically increased LV afterload has been one of the preferred methods for studying mechanisms of cardiac disease. Although aortic constriction was performed in rabbits, 31 guinea pigs, 32 and rats 33 before 1970, the development of suture-based TAC in mice in 1991 6 allowed for chronically induced afterload in a species that could readily be genetically modified. This combination has been invaluable in identifying mechanisms involved in cardiac disease. Attempts to improve the surgical protocol for suture-based TAC in mice 6 have focused on reducing trauma when accessing the aorta, 34 rather than standardization of the stenosis. More work has been performed to find good parameters for stratification and inclusion/exclusion of mice after TAC-surgery than to improve the method of constriction in itself. 7, 8, 35, 36 Suture-based TAC is largely dependent on reproducible tightening of a suture around a sizing needle. Even the best mouse surgeons will experience variations in stenosis diameter, leading to exclusion or death. Previous studies have reported that suture-based TAC using a 27G needle resulted in inner stenosis diameters ranging from $0.3-0.6 mm 8 to $0.2-0.55 mm, 37 resulting in various degrees of cardiac remodelling.
Similarly, others have reported heterogeneity in cardiac phenotypes after suture-based TAC with a 27G needle, where mice either maintain compensated hypertrophy or develop HF. 7, 9, 10 In contrast, the stenosis diameter obtained with ORAB is decided by the ID of the o-ring. This limits the possibility for constriction beyond the fixed ID and consequently leads to reproducible and consistent cardiac remodelling and disease progression. The post-operative survival rate of ORAB was 98.7%, with only two deaths from 152 operations in the first 2-week post-surgery. In comparable suture-based TAC studies, the average 2-week survival rate is 78% after constriction of the ascending aorta [38] [39] [40] and 73% after constriction of the transverse aorta. [15] [16] [17] [18] [19] 21 The majority of these early deaths are reportedly due to acute HF, suggesting excessive constriction. We believe that standardization of the constriction and avoidance of total occlusion during the procedure 41 were responsible for the negligible mortality observed with ORAB.
Another source of variation that did not occur with ORAB was band internalization. Previous studies show that the suture used for constriction can be internalized into the aortic lumen, resulting in reduced stenosis and cardiac remodelling. 7, 37 Lygate et al. 37 reported suture internalization in 25% of TAC-operated mice 4 weeks post-surgery and showed that a broader stenosis obtained by insertion of two parallel sutures abrogated this problem. As the cross section of the o-rings used for ORAB is larger than suture, we did not observe o-ring internalization even 20 weeks post-surgery. Moreover, the inert nitrile rubber material of the o-rings did not cause any adverse effects upon insertion, in line with other studies where acrylonitrile-butadiene polymers have been inserted in rats and rabbits. 42, 43 Based on these traits, we speculate that ORAB could also serve as an improved debanding model to study reverse remodelling. Suture-based debanding models of reverse remodelling in mice do exist, 44, 45 however the method is rarely used as the procedure must be performed frequently to maintain acceptable success rates. 44 As debanding may offer insight into molecular drivers of reverse remodelling, it will be interesting to see whether ORAB debanding can and will be used for this purpose in future studies. ORAB allows for grading of aortic constriction, leading to distinct cardiac patho-phenotypes important for studies of clinically relevant types of HF. In comparable suture-based TAC studies, 14, 46 constriction using needles with decreasingly smaller diameter has been tested. However, the variation in suture tightening resulted in relatively high mortality due to acute HF in all groups within 2 weeks of surgery, despite the different sizing needles. With ORAB, we avoided these limitations by using fixed diameter o-rings with various diameters. A model with transition from concentric hypertrophic remodelling to congestive, dilated HF over 20 weeks was produced by using o-rings with an ID of 0.61 mm. The ORAB 0.61 presented with a rapid increase in LV wall thickness, reduced LVID, and substantially elevated levels of natriuretic peptides and pro-hypertrophic genes. Fibrotic remodelling was present 2 weeks post-surgery along with increased transcription of pro-inflammatory genes. Left atrial and ventricular dilatation followed, with a doubling of LVEDV and pulmonary congestion after 20 weeks. The specific mechanisms involved in transition from compensatory concentric hypertrophy to congestive, dilated HF with severely impaired function (i.e. HFrEF) are yet to be elucidated. ORAB 0.61 provides a new experimental in vivo set-up to more precisely study HFrEF and transition to congested HF.
By using o-rings with an ID of 0.66 mm, we produced a model of concentric hypertrophy with progressive LV hypertrophic growth, elevated levels of natriuretic peptides, without pulmonary congestion over the 20 weeks of the study. LVEF in ORAB 0.66 stabilized 4-20 weeks postsurgery. Pro-hypertrophic, pro-fibrotic, and pro-inflammatory genes were moderately increased. Fibrosis was present at 4 weeks and increased Ctgf at 2, 4, and 20 weeks suggested fibrotic progression. During the time period with stabilized contractile function (4-20 weeks postsurgery), LV stiffness was increased, indicating that ORAB 0.66 may serve as a model for HF with mid-range reduced EF (HFmrEF), or even HF with preserved EF (HFpEF). Indeed, diastolic dysfunction with stable systolic function has been difficult to achieve experimentally using suture-based TAC due to the acuteness and severity of the increased afterload. 47, 48 Such models would be of importance for understanding molecular drivers that differ between HFrEF, HFmrEF, and HFpEF. By using ORAB 0.66 and ORAB 0.71, we induced hypertrophic LV remodelling in mice without severely compromising systolic function. Fixed diameter constrictors were introduced in guinea pigs already in the 1960s and 1970s to standardize the degree of stenosis 49 and have later been applied in rats, using metal clips. 50 These were also tested in mice. [51] [52] [53] In contrast to suture-based TAC or ORAB, clips do not induce a circular constriction as the aorta is asymmetrically distorted. Since the aorta is compressed rather than constricted, the total crosssectional area at the stenosis is difficult to control. Clips adjusted to 27, 30, and 32G needles have been applied without achieving reproducible, graded cardiac remodelling and dysfunction. [51] [52] [53] We, therefore, believe that the constriction obtained with ORAB is superior to clipconstriction with regards to stenosis standardization. Different mouse strains respond differently to pressure overload. 13, 16 In our study, we provide detailed description of the cardiac phenotype of the C57BL/6J mouse strain following ORAB, and we also observed a reproducible and graded remodelling response in FVB/N mice upon ORAB. Whether the phenotypes we observed are transferrable to other mouse strains remains to be investigated. Moreover, age-and sizematched mice should be used for ORAB and suture-based TAC, since differences in aorta diameter may influence the degree of constriction with the same o-ring or sizing needle. In summary, we have developed a novel method for high precision aortic banding in mice. ORAB offers high intra-and inter-surgeon reproducibility, low post-operative mortality, and reproducible HF phenotypes. The HF phenotypes are relevant for HFrEF, and possibly also HFpEF. We strongly believe that implementation of ORAB will increase the quality and reproducibility of pre-clinical studies of HF.
